Tolerance and pharmacokinetic interactions of rifabutin and azithromycin.

Hafner R,Bethel J,Standiford H C,Follansbee S,Cohn D L,Polk R E,Mole L,Raasch R,Kumar P,Mushatt D,Drusano G, Null Null

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2001）

引用 32|浏览17

暂无评分

摘要

This multicenter study evaluated the tolerance and potential pharmacokinetic interactions between azithromycin and rifabutin in volunteers with or without human immunodeficiency virus infection. Daily dosing with the combination of azithromycin and rifabutin was poorly tolerated, primarily because of gastrointestinal symptoms and neutropenia. No significant pharmacokinetic interactions were found between these drugs.

查看译文

关键词

area under curve

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要